Insider · CIK 0001872863
Charles Pauling Semba
Files at DMAC (DiaMedica Therapeutics Inc.). First filing -, latest -.
Charles Pauling Semba files SEC Form 4 as director at DMAC (DiaMedica Therapeutics Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Charles Pauling Semba has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | DMAC DiaMedica Therapeutics Inc. | AGrant or award Stock Option (right to buy)derivative | +40,412 | $0.00 | $0 | 40,412 | Jun 3, 2026 |
| Jan 2, 2026 | DMAC DiaMedica Therapeutics Inc. | AGrant or award Common Stock | +3,355 | $8.42 | $28k | 47,963 | Jan 6, 2026 |
| Jun 1, 2025 | DMAC DiaMedica Therapeutics Inc. | AGrant or award Stock Option (right to buy)derivative | +32,162 | $0.00 | $0 | 32,162 | Jun 3, 2025 |
| Jan 2, 2025 | DMAC DiaMedica Therapeutics Inc. | AGrant or award Voting Common Shares, no par value per share | +5,290 | $5.34 | $28k | 44,608 | Jan 3, 2025 |
Questions about Charles Pauling Semba
Answered from the filings on this page, as of the latest one.
Is Charles Pauling Semba buying or selling?
Charles Pauling Semba has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Charles Pauling Semba's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Charles Pauling Semba has 0.
Where does Charles Pauling Semba file Form 4?
Charles Pauling Semba has filed Form 4 at DMAC (DiaMedica Therapeutics Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.